{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:05:40Z","timestamp":1789610740528,"version":"build-2803163510"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1053\/j.semperi.2013.01.008","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T01:43:04Z","timestamp":1365558184000},"page":"115-123","source":"Crossref","is-referenced-by-count":46,"title":["An update on pharmacologic approaches to bronchopulmonary dysplasia"],"prefix":"10.1053","volume":"37","author":[{"given":"Sailaja","family":"Ghanta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Tropea Leeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Christou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semperi.2013.01.008_bib1","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1001\/jama.2011.1752","article-title":"Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 2225 weeks gestation","volume":"306","author":"Carlo","year":"2011","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.semperi.2013.01.008_bib2","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJMra0707601","article-title":"Management and outcomes of very low birth weight","volume":"358","author":"Eichenwald","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jpeds.2012.01.057","article-title":"Are outcomes of extremely preterm infants improving? Impact of bayley assessment on outcomes","volume":"161","author":"Vohr","year":"2012","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2013.01.008_bib4","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMra067279","article-title":"Chronic lung disease after premature birth","volume":"357","author":"Baraldi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia","volume":"163","author":"Jobe","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib6","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1542\/peds.2008-1962","article-title":"Pitfalls, problems, and progress in bronchopulmonary dysplasia","volume":"123","author":"Bhandari","year":"2009","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.siny.2009.08.002","article-title":"Prevention of bronchopulmonary dysplasia","volume":"14","author":"Laughon","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib8","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine therapy for apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib9","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/pr.2012.14","article-title":"Pentoxifylline and prevention of hyperoxia-induced lung-injury in neonatal rats","volume":"71","author":"Almario","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/14767050600736754","article-title":"Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study","volume":"19","author":"Lauterbach","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/598606","article-title":"Current pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia","author":"Tropea","year":"2012","journal-title":"Int J Pediatr"},{"key":"10.1053\/j.semperi.2013.01.008_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001453","article-title":"Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease","author":"Brion","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001453","article-title":"Aerosolized diuretics for preterm infants with (or developing) chronic lung disease","author":"Brion","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib15","article-title":"Early postnatal (<96h) corticosteroids for preventing chronic lung disease in preterm infants","author":"Halliday","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001146.pub3","article-title":"Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants","author":"Halliday","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib17","article-title":"Moderately early (7\u201314 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants","author":"Halliday","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib18","article-title":"Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants","author":"Halliday","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib19","article-title":"Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants","author":"Halliday","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1542\/peds.2010-1534","article-title":"Policy statement\u2014postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia","volume":"126","author":"Watterberg","year":"2010","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib21","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1542\/peds.2004-1159","article-title":"Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial","volume":"114","author":"Watterberg","year":"2004","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib22","unstructured":"ClinicalTrials.gov PREMILOC trial to prevent bronchopulmonary dysplasia in very preterm neonates. Clinical.Trials.gov Identifier: NCT00623740."},{"key":"10.1053\/j.semperi.2013.01.008_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2431-11-102","article-title":"Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial","volume":"11","author":"Onland","year":"2011","journal-title":"BMC Pediatr"},{"key":"10.1053\/j.semperi.2013.01.008_bib24","article-title":"Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants","author":"Shah","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib25","article-title":"Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates","author":"Shah","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000227294","article-title":"The Neonatal European Study of Inhaled Steroids (NEUROSIS): an eu-funded international randomised controlled trial in preterm infants","volume":"97","author":"Bassler","year":"2010","journal-title":"Neonatology"},{"key":"10.1053\/j.semperi.2013.01.008_bib27","unstructured":"ClinicalTrials.gov inhaled extra-fine hydrofluoalkane-beclomethasone (QVAR) in premature infants with bronchopulmonary dysplasia (BPD). ClinicalTrials.gov Identifier NCT01373008."},{"key":"10.1053\/j.semperi.2013.01.008_bib28","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-1973","article-title":"Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study","volume":"121","author":"Yeh","year":"2008","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib29","unstructured":"ClinicalTrials.gov pilot study of topical steroid for prevention of chronic lung disease in extremely premature infants. Clinical.Trials.gov identifier: NCT01268215."},{"key":"10.1053\/j.semperi.2013.01.008_bib30","unstructured":"ClinicalTrials.gov prevention of chronic lung disease (CLD) in preterm infants. clinical.Trials.gov identifier: NCT00883532."},{"key":"10.1053\/j.semperi.2013.01.008_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1203\/PDR.0b013e318142582d","article-title":"Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants","volume":"62","author":"Aghai","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.285.5.633","article-title":"Prospects for research in reproductive health and birth outcomes","volume":"285","author":"Goldenberg","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.semperi.2013.01.008_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1203\/01.PDR.0000100757.38675.50","article-title":"Pulmonary Ureaplasma urealyticum is associated with the development of acute lung inflammation and chronic lung disease in preterm infants","volume":"55","author":"Kotecha","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003744","article-title":"Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum","author":"Mabanta","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ppul.21352","article-title":"Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial","volume":"46","author":"Ballard","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1053\/j.semperi.2013.01.008_bib36","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2011-1350","article-title":"Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum-positive preterm infants","volume":"128","author":"Ozdemir","year":"2011","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib37","unstructured":"ClinicalTrials.gov clarithromycin prophylaxis in preterm infants colonisation with Ureaplasma urealyticum and Mycoplasma hominis Clinical.Trials.gov identifier: NCT01652118."},{"key":"10.1053\/j.semperi.2013.01.008_bib38","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00431-008-0746-6","article-title":"Clara cell secretory protein and bronchopulmonary dysplasia in prematurely born infants","volume":"167","author":"Greenough","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1053\/j.semperi.2013.01.008_bib39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1055\/s-0028-1090587","article-title":"Recombinant human Clara cell secretory protein treatment increases lung mRNA expression of surfactant proteins and vascular endothelial growth factor in a premature lamb model of respiratory distress syndrome","volume":"25","author":"Wolfson","year":"2008","journal-title":"Am J Perinatol"},{"key":"10.1053\/j.semperi.2013.01.008_bib40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1203\/01.PDR.0000081300.49749.87","article-title":"Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury","volume":"54","author":"Chandra","year":"2003","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1203\/01.PDR.0000156371.89952.35","article-title":"The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome","volume":"58","author":"Levine","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jaci.2006.08.009","article-title":"The role of leukotrienes in airway inflammation","volume":"118","author":"Ogawa","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.semperi.2013.01.008_bib43","unstructured":"ClinicalTrials.gov montelukast in very low birthweight infants. clinical.Trials.gov identifier: NCT00492102."},{"key":"10.1053\/j.semperi.2013.01.008_bib44","unstructured":"ClinicalTrials.gov the efficacy and safety of montelukast sodium in the prevention of bronchopulmonary dysplasia (BPD). Clinical.Trials.gov identifier: NCT01717625."},{"key":"10.1053\/j.semperi.2013.01.008_bib45","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJM199906243402505","article-title":"Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network","volume":"340","author":"Tyson","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib46","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2004-1812","article-title":"Vitamin A supplementation for extremely low birth weight infants: outcome at 18\u201322 months","volume":"115","author":"Ambalavanan","year":"2005","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1874306401206010044","article-title":"The role of surfactant in respiratory distress syndrome","volume":"6","author":"Ma","year":"2012","journal-title":"Open Respir Med J"},{"key":"10.1053\/j.semperi.2013.01.008_bib48","first-page":"221","article-title":"Immunologic consequences of exogenous surfactant administration","volume":"12","author":"Merritt","year":"1988","journal-title":"Semin Perinatol"},{"key":"10.1053\/j.semperi.2013.01.008_bib49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1203\/PDR.0b013e318175dd14","article-title":"KL4-surfactant (Lucinactant) protects human airway epithelium from hyperoxia","volume":"64","author":"Zhu","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib50","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1542\/peds.2004-2183","article-title":"A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants","volume":"115","author":"Moya","year":"2005","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib51","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.2004-2231","article-title":"A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome","volume":"115","author":"Sinha","year":"2005","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006069.pub2","article-title":"Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome","author":"Pfister","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/jamp.2009.0758","article-title":"An open label, pilot study of Aerosurf(R) combined with nCPAP to prevent RDS in preterm neonates","volume":"23","author":"Finer","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1053\/j.semperi.2013.01.008_bib54","article-title":"Surfactant lavage therapy for respiratory deterioration in extremely premature infants","author":"Iwatani","year":"2012","journal-title":"Pediatr Int"},{"key":"10.1053\/j.semperi.2013.01.008_bib55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/jp.2010.210","article-title":"Pilot trial of late booster doses of surfactant for ventilated premature infants","volume":"31","author":"Merrill","year":"2011","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2013.01.008_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1542\/peds.2007-2680","article-title":"A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia","volume":"123","author":"Laughon","year":"2009","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib57","unstructured":"ClinicalTrials.gov trial of late surfactant for prevention of bronchopulmonary dysplasia (TOLSURF). Clinical.Trials.gov identifier: NCT01022580."},{"key":"10.1053\/j.semperi.2013.01.008_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000366","article-title":"Inositol for respiratory distress syndrome in preterm infants","author":"Howlett","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib59","unstructured":"ClinicalTrials.gov single-dose intravenous inositol pharmacokinetics in preterm infants (INS-1). Clinical.Trials.gov Identifier: NCT00349726."},{"key":"10.1053\/j.semperi.2013.01.008_bib60","unstructured":"ClinicalTrials.gov multi-dose pharmacokinetics and dose ranging of inositol in premature infants (INS-2). Clinical.Trials.gov identifier: NCT01030575."},{"key":"10.1053\/j.semperi.2013.01.008_bib61","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1542\/peds.111.3.469","article-title":"Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase","volume":"111","author":"Davis","year":"2003","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib62","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1067\/S0022-3476(03)00419-0","article-title":"N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial","volume":"143","author":"Ahola","year":"2003","journal-title":"J Pediatr"},{"key":"10.1053\/j.semperi.2013.01.008_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000080089","article-title":"N-acetylcysteine administration during the first week of life does not improve lung function in extremely low birth weight infants","volume":"86","author":"Sandberg","year":"2004","journal-title":"Biol Neonate"},{"key":"10.1053\/j.semperi.2013.01.008_bib64","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1203\/00006450-199806000-00002","article-title":"Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: a pilot study","volume":"43","author":"Berger","year":"1998","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib65","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1183\/09031936.93.04020188","article-title":"Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1500g birth weight","volume":"4","author":"Watts","year":"1991","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semperi.2013.01.008_bib66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000227291","article-title":"Effects of lutein on oxidative stress in the term newborn: a pilot study","volume":"97","author":"Perrone","year":"2010","journal-title":"Neonatology"},{"key":"10.1053\/j.semperi.2013.01.008_bib67","article-title":"Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial","author":"Manzoni","year":"2012","journal-title":"Am J Perinatol"},{"key":"10.1053\/j.semperi.2013.01.008_bib68","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3345\/kjp.2010.53.6.688","article-title":"Pulmonary hypertension in infants with bronchopulmonary dysplasia","volume":"53","author":"Kim","year":"2010","journal-title":"Korean J Pediatr"},{"key":"10.1053\/j.semperi.2013.01.008_bib69","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1542\/peds.2007-0971","article-title":"Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era","volume":"120","author":"Khemani","year":"2007","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib70","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ppul.22609","article-title":"Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia","volume":"47","author":"Collaco","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1053\/j.semperi.2013.01.008_bib71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1203\/01.pdr.0000190664.69081.f1","article-title":"Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide","volume":"59","author":"Ballard","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib72","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-3428","article-title":"Inhaled nitric oxide in preterm infants: a systematic review","volume":"127","author":"Donohue","year":"2011","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib73","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1542\/peds.2010-3507","article-title":"NIH consensus development conference statement: inhaled nitric-oxide therapy for premature infants","volume":"127","author":"Cole","year":"2011","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib74","unstructured":"ClinicalTrials.gov inhaled nitric oxide to prevent and treat bronchopulmonary dysplasia (NO-BPD). Clinical.Trials.gov Identifier: NCT01503801."},{"key":"10.1053\/j.semperi.2013.01.008_bib75","unstructured":"ClinicalTrials.gov examining the use of non-invasive inhaled nitric oxide to reduce chronic lung disease in premature newborns. Clinical.Trials.gov identifier: NCT00955487."},{"key":"10.1053\/j.semperi.2013.01.008_bib76","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1164\/rccm.200503-510OC","article-title":"Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury","volume":"172","author":"Ladha","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib77","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1465-9921-10-30","article-title":"Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury","volume":"10","author":"de Visser","year":"2009","journal-title":"Respir Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib78","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/jp.2011.131","article-title":"Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?","volume":"32","author":"Nyp","year":"2012","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2013.01.008_bib79","article-title":"The effect of sildenafil on retinop-->athy of prematurity in very preterm infants","author":"Fang","year":"2012","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2013.01.008_bib80","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jaci.2007.09.018","article-title":"Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women","volume":"121","author":"Krauss-Etschmann","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.semperi.2013.01.008_bib81","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-2405","article-title":"High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes","volume":"128","author":"Manley","year":"2011","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib82","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1203\/PDR.0b013e3181f90278","article-title":"L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats","volume":"68","author":"Vadivel","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib83","first-page":"L110","article-title":"Estrogen modulates the dimensions of the lung\u2019s gas-exchange surface area and alveoli in female rats","volume":"270","author":"Massaro","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1053\/j.semperi.2013.01.008_bib84","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1203\/01.pdr.0000220360.77567.d8","article-title":"Prenatal estrogen and progesterone deprivation impairs alveolar formation and fluid clearance in newborn piglets","volume":"60","author":"Trotter","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib85","doi-asserted-by":"crossref","first-page":"F94","DOI":"10.1136\/adc.2006.097170","article-title":"Effect of oestradiol and progesterone replacement on bronchopulmonary dysplasia in extremely preterm infants","volume":"92","author":"Trotter","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1053\/j.semperi.2013.01.008_bib86","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1203\/01.PDR.0000163391.75389.52","article-title":"Effects of erythropoietin on hyperoxic lung injury in neonatal rats","volume":"58","author":"Ozer","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1053\/j.semperi.2013.01.008_bib87","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000341615","article-title":"Decrease in incidence of bronchopulmonary dysplasia with erythropoietin administration in preterm infants: a retrospective study","volume":"102","author":"Rayjada","year":"2012","journal-title":"Neonatology"},{"key":"10.1053\/j.semperi.2013.01.008_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004868.pub3","article-title":"Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"10","author":"Aher","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2013.01.008_bib89","unstructured":"ClinicalTrials.gov does erythropoietin improve outcome in very preterm infants? Clinical.Trials.gov identifier: NCT00413946."},{"key":"10.1053\/j.semperi.2013.01.008_bib90","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1164\/rccm.200902-0242OC","article-title":"Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease","volume":"180","author":"Aslam","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/2045-8932.97603","article-title":"Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension","volume":"2","author":"Hansmann","year":"2012","journal-title":"Pulm Circ"},{"key":"10.1053\/j.semperi.2013.01.008_bib92","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1164\/rccm.200902-0179OC","article-title":"Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats","volume":"180","author":"van Haaften","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib93","first-page":"L829","article-title":"Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia","volume":"302","author":"Tropea","year":"2012","journal-title":"Am J Physiol"},{"key":"10.1053\/j.semperi.2013.01.008_bib94","unstructured":"ClinicalTrials.gov safety and efficacy evaluation of PNEUMOSTEM\u00ae treatment in premature infants with bronchopulmonary dysplasia. Clinical.Trials.gov identifier: NCT01297205."},{"key":"10.1053\/j.semperi.2013.01.008_bib95","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1053\/j.semperi.2013.01.008_bib96","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.stem.2012.01.018","article-title":"Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs","volume":"10","author":"Mou","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1053\/j.semperi.2013.01.008_bib97","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1542\/peds.2011-2576","article-title":"Cell therapy: a novel treatment approach for bronchopulmonary dysplasia","volume":"130","author":"Vosdoganes","year":"2012","journal-title":"Pediatrics"},{"key":"10.1053\/j.semperi.2013.01.008_bib98","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.clp.2012.06.009","article-title":"Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia","volume":"39","author":"O\u2019Reilly","year":"2012","journal-title":"Clin Perinatol"},{"issue":"suppl 4","key":"10.1053\/j.semperi.2013.01.008_bib99","first-page":"127","article-title":"Genetic predisposing factors to bronchopulmonary dysplasia: preliminary data from a multicentre study","volume":"25","author":"Somaschini","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1053\/j.semperi.2013.01.008_bib100","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1164\/rccm.201101-0055OC","article-title":"Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants","volume":"183","author":"Laughon","year":"2011","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000513000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000513000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T16:45:58Z","timestamp":1715186758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000513000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0146000513000098"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2013.01.008","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}